Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, WADA will update and publish shortly, on its website, the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs (to be available mid-October 2021) Checklists on a number of medical conditions for which glucocorticoids may be used (to be available early November 2021) TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions (to be available early November 2021) Educational resources In addition to the guidance documents listed above, WADA has provided, or will provide, a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
In the US, EU and UK it is not approved and is sold solely as a research chemical , presented here for research and educational purposes only
Patients report more energy and better sleep when receieving the injections on a regular basis
Nevertheless, it is prudent to have regular medical supervision, so any subtle interaction or side effects can be promptly identified and managed appropriately
US$ 22.30
US$ 25.82
US$ 27.81
US$ 23.78
US$ 26.05
US$ 24.59
